Citation Impact
Citing Papers
Estrogen–serotonin interactions: implications for affective regulation
1998
Vitamin C Deficiency Facilitates 5‐S‐Cysteinyldopamine Formation in Guinea Pig Striatum
1991 StandoutNobel
5-Hydroxytryptamine pathways in anxiety and its treatment
1995
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Modulation of anxiety through blockade of anandamide hydrolysis
2002 Standout
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
1991
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
Weight Gain Associated With Neuroleptic Medication: A Review
1995
Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula
1994
Schizophrenia
2009 Standout
Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis
1991
The Role of Serotonin in Schizophrenia
1988
Neural and developmental actions of lithium: A unifying hypothesis
1989 Standout
Adolescent exposure to cannabinoids induces long-Lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons
2004
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Lack of Efficacy of Hydergine in Patients with Alzheimer's Disease
1990
Dysfunctions in Multiple Interrelated Systems as the Neurobiological Bases of Schizophrenic Symptom Clusters
1998
Infant rat separation is a sensitive test for novel anxiolytics
1991
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia
1993
Human volition: towards a neuroscience of will
2008 Standout
Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans
1991
5-HT and alcohol abuse
1992
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
A neuropsychological theory of positive affect and its influence on cognition.
1999 Standout
Region-selective activation of brain monoamine synthesis by sexual activity in the male rat
1987 StandoutNobel
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Effects of Gonadal Steroids in Women With a History of Postpartum Depression
2000 Standout
Psychiatric Aspects of Impulsivity
2001 Standout
Cocaine and Other Stimulants
1988 Standout
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs
1990
Single-dose bromocriptine reverses cocaine craving
1987
A review of the biochemical and neuropharmacological actions of lithium
1987
Dopaminergic mechanisms and cognitive deficit in schizophrenia
1979
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments
1979
Treatment of antisocial behavior in children: Current status and future directions.
1987 Standout
Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings
1979
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
A Family of cAMP-Binding Proteins That Directly Activate Rap1
1998 StandoutScience
Clozapine, Chlorpromazine, and Placebo in Newly Hospitalized, Acutely Schizophrenic Patients
1979
Dopamine and the pharmacology of schizophrenia: The state of the evidence
1974
Release of Monoamines Evoked by Field Stimulation– Studies on Some Ionic and Metabolic Requirements
1971
Effects on self-stimulation behavior of drugs influencing dopaminergic neurotransmission mechanisms
1973
Lithium in Hospitalized Aggressive Children with Conduct Disorder: A Double-Blind and Placebo-Controlled Study
1995
Psychopathology Induced by “Speed Drugs”
1981
A neural plasticity hypothesis of schizophrenia
1984
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects
1980
Drugs, Neurotransmitters, and Schizophrenia
1974 Science
Central Nervous System Alterations in Liver Cirrhosis: The Role of Portal-Systemic Shunt and Portal Hypoperfusion
2002
Postsynaptic supersensitivity in schizophrenia
1977
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
A comparison of d-aphetamine, l-amphetamine, and methamphetamine self-administration in rhesus monkeys
1973
Behavioral Efficacy of Haloperidol and Lithium Carbonate
1984
Continuous amphetamine intoxication: an animal model of the acute psychotic episode
1983
Effect of apomorphine on schizophrenic symptoms
1977
Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm
1987 StandoutNobel
Dopaminergic neurons in the rat ventral tegmental area. III. Effects of d-and l-amphetamine
1981
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
New concepts in cocaine addiction: The dopamine depletion hypothesis
1985
Précis ofThe neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system
1982 Standout
A psychomotor stimulant theory of addiction.
1987 Standout
Coping and the Stress-Induced Potentiation of Stimulant Stereotypy in the Rat
1983 Science
Effect of prostaglandin E2 on central and peripheral catecholamine neurons
1973 StandoutNobel
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
1982 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
The effect of chronic administration and withdrawal of amphetamine on cerebral dopamine receptor sensitivity
1978
Noradrenaline in the brain: Progress in theories of behavioural function
1981
3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors
1981 StandoutNobel
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP
1983 StandoutNobel
Dopamine-receptor agonist with apparent selectivity for autoreceptors: a new principle for antipsychotic action?
1982 StandoutNobel
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
1976 StandoutScience
The Dopamine Hypothesis of Schizophrenia: A Review*
1976
Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment
1983
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Bromocriptine Treatment for Cocaine Abuse: The Dopamine Depletion Hypothesis
1986
Recent advances in the phencyclidine model of schizophrenia
1991 Standout
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity
1982
Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission
1986
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Clinical Effects of Apomorphine in Schizophrenia
1984
Dopamine Receptors: From Structure to Function
1998 Standout
Exclusion of Linkage Between Schizophrenia and the D2 Dopamine Receptor Gene Region of Chromosome 11q in 112 Irish Multiplex Families
1993
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
1987 StandoutScience
Effect of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholamines
1979
Catecholamines in the Brain as Mediators of Amphetamine Psychosis
1972
The role of excitatory amino acids in neuropsychiatric illness
1990
Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy
1974
The dopamine hypothesis of schizophrenia revisited
1979
Works of S Gershon being referenced
Effect of lithium on the release of 14C-norepinephrine by nerve stimulation from the perfused cat spleen.
1971
A Pilot Study of Pathogenic Mechanisms in Amphetamine Psychosis Utilizing Differential Effects of D and L Amphetamine*
1971
Comparative Psychotomimetic Effects of Stereoisomers of Amphetamine
1971 Nature
Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
1975
Biological Basis of Psychiatric Treatment
1991
Suppression of prolactin by dopamine agonists in schizophrenics and controls
1978
GLUTAMIC ACID IN HEPATIC COMA FOLLOWING PORTACAVAL ANASTOMOSIS
1953
A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
1972
The Secretion of Lithium in Human Mixed Saliva: Effects ofIngested Lithium on Electrolyte Distribution in Saliva and Serum
1969
Effect of lithium on glycine levels in patients with affective disorders
1981
Dopamine and psychotic states: preliminary remarks.
1974
The Antagonism of Amphetamine-Induced Symptomatology by a Neuroleptic
1974
An overview of pharmacologic treatment of cognitive decline in the aged
1981
Lithium Salts in the Management of the Manic-Depressive Syndrome
1972
Effects of caloric restriction on behavior and body weight during chlorpromazine therapy.
1967
Response threshold to levodopa in psychiatric patients.
1973